icd10free.comPowered by Curo

ICD-10 Coding for Abnormal PSA(R97.20, N40.1, R97.21)

Save

Learn about ICD-10 coding for abnormal PSA, including codes R97.20 and R97.21, documentation requirements, and common pitfalls.

Also known as:
Elevated PSAAbnormal PSA reading
Related ICD-10 Code Ranges

Complete code families applicable to Abnormal PSA

R00-R99Primary Range

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

→
Code Comparison: When to Use Each Code

Compare key differences between these codes to ensure accurate selection

CodeDescription
R97.20Elevated prostate specific antigen [PSA]
R97.21Rising PSA following treatment for malignant neoplasm of prostate
Primary ICD-10-CM Codes
Elevated prostate specific antigen [PSA]
R97.20Billable
Differential Codes

Alternative codes to consider when ruling out similar conditions

Rising PSA following treatment for malignant neoplasm of prostateR97.21
Elevated prostate specific antigen [PSA]R97.20

Documentation & Coding Risks

Avoid these common issues when documenting Abnormal PSA.

Vague documentation of PSA elevation

Impact

Clinical: May lead to inappropriate follow-up or treatment., Regulatory: Potential for audit issues., Financial: Risk of claim denials.

Mitigation

Include specific PSA values, Document clinical context

Using R97.20 with G0103 for screening

Impact

Reimbursement: Incorrect coding can lead to claim denials., Compliance: Non-compliance with Medicare guidelines., Data Quality: Inaccurate data on screening vs. diagnostic PSA tests.

Mitigation

Use Z12.5 with G0103 for screening purposes.

PSA Screening vs. Diagnostic Coding

Impact

Incorrect coding of PSA tests as diagnostic when they are screening.

Mitigation

Educate staff on correct code usage and documentation requirements.

Frequently Asked Questions

Related condition guides

Documentation requirements, coding pitfalls and FAQs for conditions coded with R97.20.